sol wrote: > What I have here is Kaopectate caplets, and the active ingredient is > listed as attapulgite. No Kaolin, no pectin. Pectin is 6th in line in > the inactive ingredients listing. > What???
That is a trick used to get around FDA requirements of proof for claims. For instance, lets say you want to market CS as an anti viral medicine. You don't want to spend 100 million dollars getting it approved, but you still want to label the product as antiviral. So what you do is put in a trace of an antiviral that IS FDA approved and list it as an active ingredient, but then put CS in as an inactive ingredient. Then it works a million times better than the actual active ingredient alone would, and it keeps the FDA off your back. In fact there was an article in the paper about this just the other day. Turns out that they can put almost anything in as an inactive ingredient, and not label it. That in turn can cause severe problems for some people who may be allergic to it, and they can never find out what it is that is causing the problem because it is an unlabelled inactive ingerdient. The FDA is being pushed to require listing of all ingredients, but the pharms are fighting it because it would then allow everyone to see what is in many cases making it work so much better than the competition's brand of what is suppose to be the same thing.. Marshall > > paula > ----- Original Message ----- > From: "Charles Sutton" <[email protected]> > > > a quick search on google will show it is clay, mined directly from > the > > ground. Florida is a producer, but not much compared to Africa. > > > > > > > > > forgot to add that the clay is kaolin and pectin is from the > apple. You > > can > > > > buy Kaopectate in any drugstore. > > -- > The silver-list is a moderated forum for discussion of colloidal silver. > > Instructions for unsubscribing may be found at: http://silverlist.org > > To post, address your message to: [email protected] > > Silver-list archive: http://escribe.com/health/thesilverlist/index.html > > List maintainer: Mike Devour <[email protected]>
